TNFR2 was expressed in the ducts of pancreatic cancer tissue to varying levels and we divided 70 PDAC patients into two groups by TNFR2 IHC score: low-expression group (+, ++) and high-expression group (+++). This evidence concerns the gene TNFRSF1B and pancreatic neoplasm.